Mechanisms that monitor the folding states of polypeptides are found throughout the cell. In the cytosol, how misfolded proteins are recognized and degraded is poorly understood. Here, misfolded proteins are shown to traffic to the nucleus where they are ubiquitinated by the San1p E3 ubiquitin ligase and degraded by the 26S proteasome.
Intracellular quality control systems monitor protein conformational states. Irreversibly misfolded proteins are cleared through specialized degradation pathways. Their importance is underscored by numerous pathologies caused by aberrant proteins. In the cytosol, where most proteins are synthesized, quality control remains poorly understood. Stress-inducible chaperones and the 26S proteasome are known mediators but how their activities are linked is unclear. To better understand these mechanisms, a panel of model misfolded substrates was analyzed in detail. Surprisingly, their degradation occurs not in the cytosol but in the nucleus. Degradation is dependent on the E3 ubiquitin ligase San1p, known previously to direct the turnover of damaged nuclear proteins. A second E3 enzyme, Ubr1p, augments this activity but is insufficient by itself. San1p and Ubr1p are not required for nuclear import of substrates. Instead, the Hsp70 chaperone system is needed for efficient import and degradation. These data reveal a new function of the nucleus as a compartment central to the quality control of cytosolic proteins.
The central dogma of molecular biology—DNA to RNA to protein—concisely describes the information flow of protein synthesis. Errors arising at any step can disrupt protein folding and lead to potentially toxic products. Although DNA replication is highly accurate, transcriptional and translational error rates can be as high as 10−4 and 10−3, respectively (
Although found everywhere proteins are made, the best understood PQC mechanisms are in the endoplasmic reticulum (ER). As the site of secretory protein synthesis all the factors needed for folding reside there. Accordingly, ER quality control mechanisms have the added responsibility to control trafficking to prevent the premature exit of folding intermediates (
At first glance, protein quality control in the cytosol is expected to be simpler, but it presents its own set of challenges. Because protein synthesis is not limited to a controlled compartment like the ER, folding intermediates and aberrant products could encounter a wider array of molecules and interfere with their functions. A recurring strategy to prevent inappropriate interactions is to partition aberrant proteins to discrete sites or compartments. Proteins that aggregate in the cytosol form large complexes called “aggresomes” and segregated to a perinuclear site (
To be effective, quality control mechanisms must deploy a reliable means to differentiate misfolded proteins from normal proteins, folding intermediates, and presecretory proteins. Cytosolic protein quality control mechanisms, recently termed CytoQC (
Despite these recent advancements, the mechanisms used to sort, ubiquitinate, and degrade substrates in CytoQC remain unclear. In this study, detailed analyses of CytoQC revealed a dynamic system where nuclear compartmentalization of key functions plays a central role in substrate recognition and turnover.
Plasmids were constructed using standard cloning protocols (
pES76 encodes full-length CPY*-HA in pRS315 (
The
pRP42 (ΔssPrA-HA) was constructed by deleting sequences encoding the first 22 residues of PrA-HA by site-directed mutagenesis using primer RP29 and pRP58 as the template. pRP44 (Δ2GFP-HA) was made by deleting sequences encoding amino acids 25 through 36 by site-directed mutagenesis on pRP61 using primer RP65.
pRP51 and pRP52 expresses ΔssPrA-HA and Δ2GFP-HA from
The
The
Cells were grown synthetic complete media (SC) lacking methionine, cysteine, and components for plasmid selection where applicable; 3.0 OD600 units of cells were labeled with 82.5 μCi of [35S]methionine/cysteine (EasyTag EXPRESS 35S, Perkin Elmer-Cetus, Waltham, MA) and chased with excess cold amino acids for times indicated. For galactose induction, cells were incubated for 4 h in 2% galactose media before experiments. Protein immunoprecipitation and resolution by SDS-PAGE is carried as described (
Cells were grown to midlog phase in synthetic media. Cessation of protein synthesis was initiated by adding cycloheximide to 200 μg/ml to begin the chase. At each time point, the chase was terminated by transferring an aliquot of cells into 1 ml ice-cold 10% trichloroacetic acid (TCA). Detergent lysates were prepared by mechanical cell disruption and TCA precipitation as described previously (
Cells expressing misfolded proteins were resuspended in 10% TCA chilled on ice. After bead beating, precipitated proteins were pelleted by centrifugation at 14000 rpm for 10 min at 4°C. The pellet was resuspended in TCA resuspension solution (3% SDS, 100 mM Tris-base, 3 mM DTT). Protein sample, 50 μl, was mixed with 550 μl of IPS II (50 mM Tris-Cl, pH 7.4, 150 mM NaCl, and 1% Triton X-100), 6 μl of protease inhibitor cocktail (Roche, Nutley, NJ), and 6 μl of 100 mM PMSF. Misfolded proteins were immunoprecipitated and detected by anti-HA antibody. The ubiquitinated proteins were detected by using anti-ubiquitin antibody.
Cells expressing wild-type or mutant proteins were harvested and resuspended in cytosol buffer (20 mM HEPES, pH 7.4, 14% glycerol, 100 mM KOAc, and 2 mM MgOAc) and disrupted by bead beating for five 1-min full-speed cycles on a vortex mixer. For assays of PrA and ΔssPrA, Triton X-100 was added to lysates (to 1% vol/vol). After 5-min incubation at 30°C, trypsin was added at 5.0 μg/ml and incubated at 30°C. A portion was removed at each time point, and the reaction was terminated by adding TCA to 10% and proteins precipitated on ice. The recovered proteins were analyzed by SDS-PAGE/Western blotting analysis using the relevant antibodies.
Indirect immunofluorescence was performed as described previously (
Cells overexpressing NLS-GFP-NES or NLS-GFP-P12 were grown at room temperature and shifted to 23, 30, or 37°C for 1 h. Cells were incubated for 5 min with Hoechst 33342 (Invitrogen) before viewing. Cells were examined by confocal microscopy using Axio Imager.M1 microscope with 100 × 1.4 NA oil Plan- Aprochromat objective (Carl Zeiss MicroImaging). Images were archived by LSM Image Browser (Zeiss) and Adobe Photoshop.
Cells expressing target substrates were harvested and suspended in lysis buffer (50 mM HEPES-KOH, pH 7.4, 250 mM sorbitol, 150 mM KOAc, and 5 mM MgOAc) containing 1 mM PMSF. Cells were mechanically disrupted with zirconium beads by vortexing at full speed (1 min vortex and 1 min on ice, 10 cycles). The lysate was clarified by centrifugation at 14,000 rpm for 5 min at 4°C twice. NaCl (final 0.5 M), Triton X-100 (final 0.5%), and protease inhibitor cocktail was added to the clarified lysate. IgG beads (GE Biosciences, Fairfield, CT) were added, and the mixture was gently rotated at 4°C for 2 h. Beads were washed three times with lysis buffer containing 0.5% Triton X-100. The bound proteins to beads were eluted, separated by SDS-PAGE, and detected on immunoblots.
Wolf and colleagues created ΔssCPY*, a model CytoQC substrate, by deleting the CPY* signal sequence (
ΔssPrA and Δ2GFP are substrates of CytoQC. (A) Schematic representation of wild-type and mutant PrA and GFP proteins. All constructs are appended with a C-terminal HA epitope tag. ss, signal sequence. Branched symbols represent N-linked glycans. (B) Trypsin sensitivity assay. Postnuclear lysates prepared from wild-type cells expressing PrA, ΔssPrA, GFP, or Δ2GFP were incubated with 5.0 μg/ml trypsin for the times shown. Proteins were analyzed with immunoblots using monoclonal anti-HA antibody (PrA and ΔssPrA) and anti-GFP antibody (GFP and Δ2GFP). Endogenous 3-phophoglycerate kinase (PGK) was detected as an endogenous folded protein control. The GFP lysate was diluted 10-fold due to its higher steady-state level. (C) Stability of substrate proteins in vivo. Wild-type cells were pulse-labeled for 10 min and chased for the times indicated at 30°C. Immunoprecipitated proteins were resolved by SDS-PAGE and quantified using a phosphorimager. Representative phosphor screen scans are shown. Error bars, the SD of three independent experiments. (D) Turnover of ΔssPrA and Δ2GFP requires CytoQC chaperones. Pulse-chase analysis was performed in
An in vitro trypsinization assay was applied to assess the folding states of ΔssPrA and Δ2GFP. Unfolded proteins typically exhibit protease hypersensitivity compared with folded proteins (
Next, the intracellular localization of the model substrates was analyzed by indirect immunofluorescence combined with confocal imaging. Surprisingly, ΔssPrA displayed strong nuclear staining in addition to the expected, but weaker, cytosolic staining (
ΔssPrA and Δ2GFP are localized in the cytosol and nucleus. Cells were prepared for indirect immunofluorescence as described in
E3 ubiquitin ligases are a broad class of factors often responsible for substrate recognition (
San1p is required for ΔssPrA and Δ2GFP ubiquitination and degradation. (A) Substrate turnover in wild type and Δ
To determine if San1p interacts with substrates, coimmunoprecipitation experiments were performed. For this purpose, a functional V5-tagged San1p was introduced into MG132-sensitized cells expressing ΔssPrA, Δ2GFP, or no substrate. Cells were treated with MG132 for 4 h to stabilize substrates, and detergent extracts were prepared under nondenaturing conditions. Cell extracts were next subjected to immunoprecipitation with anti-HA antibody. Isolated proteins were resolved by SDS-PAGE and blotted onto nitrocellulose filters probed with anti-V5 and anti-HA antibodies. As shown in
San1p overexpression enhances substrate degradation. (A) To analyze San1p:substrate interactions, San1p-V5 was coexpressed with ΔssPrA or Δ2GFP in drug sensitized cells. Cells were treated with MG132 (20 μM) to stabilize substrates. Substrate proteins were immunoprecipitated under nondenaturing conditions and protein complexes were resolved by SDS-PAGE and transferred to nitrocellulose. Membranes were probed using anti-HA antibody to detect substrates and anti-V5 antibody to detect San1p-V5. Proteins were visualized by enhanced chemiluminescence. (B) Substrate steady state levels in wild-type and San1p-V5 (OE) cells were analyzed by immunoblotting. Substrates and San1p-V5 were detected by anti-HA and anti-V5 antibody respectively. Detection of Sec61p was used as a loading control. (C) Substrate turnover rates in wild-type and San1p-overexpressing (OE) cells were determined by pulse-chase analysis as in
In this study, ΔssPrA and Δ2GFP were expressed from the strong
In the above experiment, substrate turnover rates were increased marginally in cells bearing reduced substrate loads, an indication of limiting factors in CytoQC (compare Figure S2D to
To visualize the site of decay, a cycloheximide chase assay was combined with indirect immunofluorescence. In wild-type cells, ΔssPrA localizes mostly to the nucleus before cycloheximide addition (
Visualization of intracellular substrate decay. Logarithmically growing wild-type and Δ
Ubr1p, the E3 ubiquitin ligase for substrates of the “N-end rule” degradation mechanism (
Ubr1p augments the San1p system. (A) Turnover rates of ΔssPrA and Δ2GFP in wild type, Δ
The loss of cytoplasmic Hsp70 function shuts down the turnover of misfolded cytosolic proteins (
First, single deletion mutants were generated and tested for their ability to degrade ΔssPrA and Δ2GFP. Pulse-chase analysis shows that no single
Ssa1p and Ssa2p are required for substrate degradation and nuclear localization. (A) Stability of ΔssPrA and Δ2GFP was examined in the wild type and Δ
To determine whether Ssa proteins bind CytoQC substrates before degradation, FLAG-tagged Ssa1p was introduced into the Δ
Next, we sought to understand the roles Ssa1p and Ssa2p play in CytoQC. For this, we performed indirect immunofluorescence to visualize the fate of substrates stabilized in the Δ
The Hsp70 nucleotide exchange factor Sse1p (Hsp110) is required for the degradation of misfolded VHL tumor suppressor in yeast cells (
Sse1p is required for substrate degradation. (A) Turnover rates of ΔssPrA and Δ2GFP in wild-type and Δ
The accumulation of aberrant proteins in the cytosol and nucleus is associated with numerous human diseases including Parkinson's and Huntington's (
The nucleus accounts for over 80% of proteasomes at steady state throughout the cell cycle (
In the ER, multiple quality control pathways are deployed to handle the diversity of proteins that traffic through. Each is composed of specialized factors structured around a specific E3 ubiquitin ligase to handle a defined set of client substrates (
In addition to San1p and Ubr1p/Ubr2p, evidence exists for a third CytoQC pathway. Doa10p, the ERAD E3 ubiquitin ligase that recognizes misfolded cytosolic domains of membrane proteins, is also required for the cytosolic degradation of mutant Ura3p (Ura3-2p and Ura3-3p) and a Ura3p-CL1 fusion protein (
A recent study proposed that misfolded proteins partition between subcellular compartments termed JUNC and IPOD, depending on their physical states before they are degraded (
It is becoming clear that protein quality control in the cytosol follows the general paradigm established for ERAD pathways. That is, multiple pathways and mechanisms exist to handle the diversity of substrates. However, unlike ERAD, where topological constraints makes the rationale for divergent mechanisms more transparent, the need for multiple mechanisms in CytoQC is unclear. Perhaps the answer could be found in how the E3 enzymes recognize their substrates. The three E3s are not functionally redundant. All substrates display degradation defects in at least one of the singly deleted strains. For example, stGnd1p is entirely Ubr1p-dependent, whereas ΔssPrA and Δ2GFP are almost entirely San1p-dependent (
This article was published online ahead of print in
We thank Randy Hampton, Richard Gardner, and Avrom Caplan for communicating their unpublished data. We thank the members of the Ng Lab for discussion and comments. We are grateful to Karsten Weis, Jeff Brodsky, Reid Gilmore, Tom Stevens, and Peter Walter for strains and antibodies. This work is supported by funds from the Temasek Trust and a National University of Singapore Graduate Scholarship to R.P.